Däster Silvio, Eppenberger-Castori Serenella, Hirt Christian, Soysal Savas D, Delko Tarik, Nebiker Christian A, Weixler Benjamin, Amicarella Francesca, Iezzi Giandomenica, Governa Valeria, Padovan Elisabetta, Mele Valentina, Sconocchia Giuseppe, Heberer Michael, Terracciano Luigi, Kettelhack Christoph, Oertli Daniel, Spagnoli Giulio C, von Holzen Urs, Tornillo Luigi, Droeser Raoul A
Department of Surgery; University Hospital Basel ; Basel, Switzerland ; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
Institute of Pathology; University Hospital Basel ; Basel, Switzerland.
Oncoimmunology. 2015 May 29;4(12):e1050574. doi: 10.1080/2162402X.2015.1050574. eCollection 2015 Dec.
Colorectal cancer (CRC) infiltration by cells expressing myeloperoxidase (MPO) or CD8 positive T lymphocytes has been shown to be independently associated with favorable prognosis. We explored the relationship occurring between CD8+ and MPO+ cell CRC infiltration, its impact on clinical-pathological features and its prognostic significance in a tissue microarray (TMA) including 1,162 CRC. We observed that CRC showing high MPO+ cell infiltration are characterized by a prognosis as favorable as that of cancers with high CD8+ T cell infiltration. However, MPO+ and CD8+ CRC infiltrating cells did not synergize in determining a more favorable outcome, as compared with cancers showing MPO/CD8 or MPO/CD8 infiltrates. Most importantly, we identified a subgroup of CRC with MPO/CD8 tumor infiltration characterized by a particularly severe prognosis. Intriguingly, although MPO+ and CD8+ cells did not co-localize in CRC infiltrates, an increased expression of TIA-1 and granzyme-B was detectable in T cells infiltrating CRC with high MPO+ cell density.
已显示,表达髓过氧化物酶(MPO)的细胞或CD8阳性T淋巴细胞浸润结直肠癌(CRC)与良好预后独立相关。我们在一个包含1162例CRC的组织微阵列(TMA)中,探讨了CD8 +和MPO +细胞浸润CRC之间的关系、其对临床病理特征的影响及其预后意义。我们观察到,MPO +细胞浸润高的CRC的预后与CD8 + T细胞浸润高的癌症一样良好。然而,与显示MPO/CD8或MPO/CD8浸润的癌症相比,MPO +和CD8 + CRC浸润细胞在确定更有利的结果方面并未协同作用。最重要的是,我们确定了一个MPO/CD8肿瘤浸润的CRC亚组,其预后特别差。有趣的是,尽管MPO +和CD8 +细胞在CRC浸润中不共定位,但在MPO +细胞密度高的浸润CRC的T细胞中可检测到TIA-1和颗粒酶B的表达增加。